MPM
MRVI icon

Meritage Portfolio Management’s Maravai LifeSciences MRVI Stock Holding History

Meritage Portfolio Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,880
Closed -$279K – 347
2023
Q3 		$279K Buy
27,880
+1,175
+4% +$12.9K 0.02% 293
2023
Q2 		$332K Buy
+26,705
New +$360K 0.02% 286

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meritage Portfolio Management's MRVI Position: Q4 2023 in Review

Meritage Portfolio Management sold out of Maravai LifeSciences (MRVI) in Q4 2023, closing a stake of 27,880 shares — an estimated $279K sold.

Meritage Portfolio Management first reported a position in MRVI in Q2 2023 and held it in 2 quarters. The position peaked at $332K in Q2 2023. 223 funds tracked by Wall St. Rank hold MRVI as of Q4 2023.

  • Meritage Portfolio Management reported no remaining Maravai LifeSciences position as of Q4 2023 after selling out during the quarter.
  • Meritage Portfolio Management sold 27,880 Maravai LifeSciences shares in Q4 2023, an estimated $279K.
  • Meritage Portfolio Management first reported a position in Maravai LifeSciences in Q2 2023 and held it in 2 quarters.
  • Meritage Portfolio Management's Maravai LifeSciences position peaked at $332K in Q2 2023.
  • 223 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2023.

Based on Meritage Portfolio Management's 13F filing for Q4 2023, filed 2 Feb 2024.